Skyscape Web Viewer : Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs : Main Index

View All
About
absolute neutrophil count (ANC) Answer 11.4 Answer 3.5 Answer 3.2 Question 3.2
ACT
acute kidney injury (AKI) Antifolate Toxicities and Supportive Agents Question 3.4
acute lymphoblastic leukemia (ALL) Answer 5.2 Immunotherapeutics Including Vaccines, Bispecifics, CAR-T, and Checkpoint Inhibitors Purine Analogs Question 3.7 Asparaginases, as Amidohydrolases, Possess Both Asparaginase and Glutaminase Activity Polymorphism in Thiopurine Methyltransferase (TPMT) Question 3.6 Question 5.2
acute myeloid leukemia (AML) Question 15.1 Targeted Therapies (Small Molecules) Question 15.3
acute promyelocytic leukemia (APL) Question 8.1 Differentiating Agents and Microenvironment
ADA
ADCC
ABC
ACTH
acute respiratory distress syndrome (ARDS)
adenosine deaminase (ADA)
adenosine triphosphate (ATP) Tyrosine Kinase Inhibitors (TKI) Targeted Therapies (Small Molecules)
adrenocorticotropic hormone (ACTH) Chemical Structures of Abiraterone and its Prodrug, Abiraterone Acetate Sources of and rogens in the Human Prostate Male Hormonal Therapies
adverse effect (AE)
AIs
alanine aminotransferase (ALT)
aldehyde dehydrogenase (ALDH)
ALK
Alkylating agents ethylenimines nitrosoureas treatment goal cyclophosphamide and ifosfamide methylguanine methyltransferase, clinical importance platinum compounds triazines (three attached nitrogen atoms)
ALL
allo-hematopoietic stem cell transplantation (HSCT) Answer 15.4 Answer 15.3 Mechanism of Action of High-Dose Cyclophosphamide Graft-Versus-Host Disease (GVHD) Prophylaxis Question 15.2 Question 15.4 Answer 15.5 Question 15.1 Question 15.3 Transplant-Related Agents
ADC
ADCP
adoptive T-cell therapies (ACT)
ADT
AE
AKI
alanine transaminase (ALT)